Searchable abstracts of presentations at key conferences in endocrinology

ea0026p8 | Adrenal cortex | ECE2011

Validation of the disease-specific quality of life questionnaire AddiQoL in European Addison patients

Oksnes M , Lovas K

Introduction: Patients with Addison’s disease (AD) self-report impairment in specific dimensions on well-being questionnaires. An AD disease-specific quality of life questionnaire (AddiQoL) was developed to aid evaluation of patients. We here aimed to validate translated questionnaires in terms of internal consistency and reliability and to improve the construct of the scale.Methods: After translation by a multistep approach, the final versions were...

ea0029p63 | Adrenal cortex | ICEECE2012

Genetic, anthropometric and metabolic features of adult norwegian patients with 21-hydroxylase deficiency

Nermoen I. , Bronstad I. , Fougner K. , Svartberg J. , Oksnes M. , Husebye E. , Lovas K.

Objective: The aim of this study was to determine genetic, anthropometric and metabolic features in an unselected population of adult Norwegian patients with classical 21-hydroxylase deficiency (21OHD).Patients,Methods, and design: Sixty-four 21OHD-patients participated (23 men, 41 women; mean age 40.3 (range 19–72) in a cross-sectional study including DNA sequencing of the CYP21A1P-CYP21A2 locus, anthropometric measurements i...

ea0029oc7.5 | Adrenal Clinical | ICEECE2012

Continuous subcutaneous hydrocortisone infusion (CSHI) as replacement therapy in Addison’s disease (AD)

Oksnes M. , Bjornsdottir S. , Methlie P. , Bratland E. , Isaksson M. , Kampe O. , Hulting A. , Bensing S. , Husebye E. , Lovas K.

Background: Conventional glucocorticoid replacement therapy is unphysiological, and does not restore quality-of-life in AD. Here we evaluated the dosing regimens and glucocorticoid metabolism in 10 patients undergoing 24 h sampling during oral replacement therapy and CSHI.Design, Subjects, Measurements: We set up a cross-over randomised multi-centre clinical trial to evaluate dosage and effects of CSHI in 40 Scandinavian AD patients, comparing 3 months o...